Krystal Biotech (KRYS) Shares Outstanding (2016 - 2026)

Krystal Biotech has reported Shares Outstanding (Entity) for 11 years, with the latest figure at $29.6 million in Q2 2026.

• Shares Outstanding (Entity) for Q2 2026 came in at $29.6 million, up 2.31% year-over-year; the trailing twelve-month figure through Jun 2026 was $29.6 million (up 2.31% YoY), and the FY2025 annual result was $29.2 million, up 1.38% from the prior year.
• Shares Outstanding (Entity) climbed to $29.6 million in Q2 2026, from $29.4 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $29.6 million in Q2 2026 and troughed at $25.2 million in Q1 2022.
• A 5-year average of $27.9 million and a median of $28.6 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The widest annual swing landed in 2022, when Shares Outstanding (Entity) gained 15.61%; it then gained 0.76% in 2025.
• A 5-year view of Shares Outstanding (Entity) shows it stood at $25.8 million in 2022, then rose by 9.6% to $28.2 million in 2023, then climbed by 1.97% to $28.8 million in 2024, then grew by 1.38% to $29.2 million in 2025, then rose by 1.38% to $29.6 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $29.6 million in Q2 2026, $29.4 million in Q1 2026, and $29.2 million in Q4 2025.